Coexistence of KRAS mutation with mutant but not wild-type EGFR predicts response to tyrosine-kinase inhibitors in human lung cancer

Absztrakt
Leírás
Kulcsszavak
Forrás
British Journal Of Cancer. -111 : 11 (2014), p. 2203-2204. -Br. J. Cancer. - 0007-0920